-
Australia bans under-16s from social media in world-first crackdown
-
US Fed appears set for third rate cut despite sharp divides
-
Veggie 'burgers' at stake in EU negotiations
-
Haitians dance with joy over UNESCO musical listing
-
Suspense swirls if Nobel peace laureate will attend ceremony
-
UK public urged to keep eyes peeled for washed-up bananas
-
South Korea chip giant SK hynix mulls US stock market listing
-
Captain Cummins back in Australia squad for third Ashes Test
-
NFL Colts to bring 44-year-old QB Rivers out of retirement: reports
-
West Indies 92-2 after being asked to bat in second New Zealand Test
-
Ruckus in Brazil Congress over bid to reduce Bolsonaro jail term
-
ExxonMobil slows low-carbon investment push through 2030
-
Liverpool's Slot swerves further Salah talk after late Inter win
-
Maresca concerned as Atalanta fight back to beat Chelsea
-
Liverpool edge Inter in Champions League as Chelsea lose in Italy
-
Spurs sink Slavia Prague to boost last-16 bid in front of Son
-
Arsenal ensure Women's Champions League play-off berth
-
Late penalty drama helps Liverpool defy Salah crisis at angry Inter
-
Canada launches billion dollar plan to recruit top researchers
-
Liverpool defy Salah crisis by beating Inter Milan in Champions League
-
Honduran leader alleges vote tampering, US interference
-
De Ketelaere inspires Atalanta fightback to beat Chelsea
-
Kounde double helps Barcelona claim Frankfurt comeback win
-
US Supreme Court weighs campaign finance case
-
Zelensky says ready to hold Ukraine elections, with US help
-
Autistic Scottish artist Nnena Kalu smashes Turner Prize 'glass ceiling'
-
Trump slams 'decaying' and 'weak' Europe
-
Injury-hit Arsenal in 'dangerous circle' but Arteta defends training methods
-
Thousands flee DR Congo fighting as M23 enters key city
-
Karl and Gnabry spark Bayern to comeback win over Sporting
-
Thousands flee DR Congo fighting as M23 closes on key city
-
Zelensky says ready to hold Ukraine elections
-
Indigenous artifacts returned by Vatican unveiled in Canada
-
Ivory Coast recall Zaha for AFCON title defence
-
Communist vs Catholic - Chile prepares to choose a new president
-
Trump's FIFA peace prize breached neutrality, claims rights group
-
NHL 'optimistic' about Olympic rink but could pull out
-
Thousands reported to have fled DR Congo fighting as M23 closes on key city
-
Three face German court on Russia spying charges
-
Amy Winehouse's father sues star's friends for auctioning her clothes
-
Woltemade's 'British humour' helped him fit in at Newcastle - Howe
-
UK trial opens in dispute over Jimi Hendrix recordings
-
Pandya blitz helps India thrash South Africa in T20 opener
-
Zelensky says will send US revised plan to end Ukraine war
-
Nobel event cancellation raises questions over Machado's whereabouts
-
Miami's Messi wins second consecutive MLS MVP award
-
Trump slams 'decaying' Europe and pushes Ukraine on elections
-
TotalEnergies in deal for Namibia offshore oil field
-
Jesus added to Arsenal's Champions League squad
-
Red Bull part ways with influential advisor Marko
Seven deaths in E.Guinea from Marburg virus, 20 others likely linked: WHO
Seven people have been killed in an outbreak of Marburg virus in Equatorial Guinea, with a further 20 deaths "probably" due to the hemorrhagic fever, the World Health Organization said Thursday.
The outbreak of the virus, which is almost as deadly as Ebola, has now spread beyond the province of Kie-Ntem, where it caused the first known deaths in January.
It has reached Bata, the economic capital of the small central African country, according to the government.
The spread of Marburg "is a critical signal to scale up response efforts to quickly stop the chain of transmission and avert a potential large-scale outbreak and loss of life," said Dr Matshidiso Moeti, the WHO's regional director for Africa.
Since the start of the outbreak, "there have been a total of nine laboratory-confirmed cases and 20 probable cases", the WHO said in a report on its website.
"Of the nine laboratory-confirmed cases, seven people have died and all probable cases have died."
Among the 20 probable cases, the patients had all the symptoms of the disease and had been in contact with confirmed cases, but samples could not be taken from their bodies, or they could not be treated, a WHO official told AFP Thursday.
The new cases have been reported from Kie-Ntem in the east, Litoral in the west and the Centro Sur provinces, all of which have borders with Cameroon and Gabon.
The epidemic is therefore now a serious problem in three of Equatorial Guinea's four mainland provinces.
- 'High alert' -
In eastern Africa, Tanzania said Tuesday that five people had died from the virus, while neighbouring Uganda, which had its last outbreak in 2017, said it was on "high alert".
The WHO said additional experts in epidemiology, logistics, health operations and infection prevention and control would be deployed in the coming days.
The agency is also supporting the health authorities in neighbouring Cameroon and Gabon to ramp up outbreak readiness and response capabilities.
The Marburg virus causes severe fever, often accompanied by bleeding and organ failure.
It is part of the so-called filovirus family that also includes Ebola, which has wreaked havoc in several previous outbreaks in Africa.
The suspected natural source of the Marburg virus is the African fruit bat, which carries the pathogen but does not fall sick from it.
The virus takes its name from the German city of Marburg, where it was first identified in 1967, in a lab where workers had been in contact with infected green monkeys imported from Uganda.
The animals can pass the virus to primates in close proximity, including humans, and human-to-human transmission then occurs through contact with blood or other body fluids.
Fatality rates in confirmed cases have ranged from 24 percent to 88 percent in previous outbreaks, depending on the virus strain and case management, according to WHO.
There are currently no vaccines or antiviral treatments, but potential treatments, including blood products, immune therapies and drug therapies, as well as early candidate vaccines, are being evaluated, the WHO says.
L.Adams--AT